Other official information and services: www.belgium.be
Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
2019C512 Product name: Durvalumab
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
- Application number:
- 2019C/512
- Type:
- Certificate
- SPC type:
- Medical
- Basic patent number:
- 009593948
- Status:
- Deemed Withdrawn
- Publication number:
- 2019C512
- 1rst applicant's nationality:
- Procedural language:
- Dutch
Marketing authorization
- Marketing authorization number:
- EU/1/18/1322
- Marketing authorization type:
- National/EU
- Designates country:
- No
- Marketing authorization date:
- 21/09/2018
- Marketing authorization status:
- Accepted
- Marketing authorization country:
- Belgium (BE)
Dates
- Filing date:
- 20/03/2019
- First marketing authorization date:
- 21/09/2018
- Grant date:
- Activation date:
- BE Publication date:
- 29/03/2019
- Lapsed date:
- Expiration date (if granted and all annual fees paid):
- Basic SPC Expiration (if granted and all annual fees paid):
- 23/08/2025
- SPC/SPC Extension Expiration (if granted and all annual fees paid):
- 23/08/2025
- Rejection date:
- 20/08/2020
- Withdrawal date:
Applicant
1
- Name:
- Dana-Farber Cancer Institute, Inc.
- Legal Form:
- From:
- 29/03/2019
- Address:
- 450 Brookline Avenue, Boston, MA 02215, United States (US)
- To:
2
- Name:
- Genetics Institute, LLC
- Legal Form:
- From:
- 29/03/2019
- Address:
- 87 Cambridge Park Drive, Cambridge, MA 02140, United States (US)
- To:
Agent
- Name:
- BRANTSANDPATENTS
- Legal Form:
- From:
- 21/03/2019
- Address:
- Pauline Van Pottelsberghelaan 24, 9051, GENT, Belgium (BE)
- To:
Publication
Bulletin
1
- Bulletin heading:
- SPC
- Journal edition number:
- 2019/09
- Publication date:
- 08/05/2019
- Description:
- Contains data concerning applications for- or granted Supplementary Protection Certificates
2
- Bulletin heading:
- VRV
- Journal edition number:
- 2020/22
- Publication date:
- 12/10/2020
- Description:
- Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)
Annual fee
- Annual fee(s) Due Date:
- Annual fee number:
- Expected payer:
- Last annual fee payment date:
- 30/07/2020
- Last annual fee paid number:
- 21
- Last annual fee paid amount:
- 650 Euro
- Payer:
- COMPUTER PACKAGES INC.
| Filing date | Document type | Publication Type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|---|
| 29/03/2019 | Front Page | 1 | /1/6/6/4/3/0721834661/docs/2019c512_0_i1frontpage_20190329_094941940.pdf | ||||
| 21/03/2019 | General Document | Other | 2 | /1/6/6/4/3/0721834661/docs/2019c512_1_generaldocument_20190322_082415993.pdf | |||
| 09/09/2019 | General Document | Other | 2 | /1/6/6/4/3/0721834661/docs/2019c512_2_generaldocument_20190910_082306363.pdf | |||
| 18/03/2020 | General Document | Other | 10 | /1/6/6/4/3/0721834661/docs/2019c512_3_generaldocument_20200319_082207214.pdf | |||
| 27/01/2021 | Outgoing Correspondence | 4 | /1/6/6/4/3/0721834661/docs/2019c512_4_outgoingcorrespondence_20210201_040902076.pdf | ||||
| 14/01/2020 | Incoming Correspondence (Email) | Cover letter | 1 | /1/6/6/4/3/0721834661/docs/2019c512_5_incomingcorrespondenceelectronic_20200115_082404947.pdf | |||
| 20/03/2019 | Application Form | 4 | /1/6/6/4/3/0721834661/docs/2019c512_6_applicationform_20190321_082331132.pdf | ||||
| 21/03/2019 | General Document | Other | 3 | /1/6/6/4/3/0721834661/docs/2019c512_7_generaldocument_20190322_082417685.pdf | |||
| 09/09/2019 | Incoming Correspondence (Email) | Cover letter | 1 | /1/6/6/4/3/0721834661/docs/2019c512_8_incomingcorrespondenceelectronic_20190910_082303419.pdf | |||
| 09/09/2019 | General Document | Other | 10 | /1/6/6/4/3/0721834661/docs/2019c512_9_generaldocument_20190910_082303866.pdf | |||
| 06/08/2019 | Outgoing Correspondence | 1 | /1/6/6/4/3/0721834661/docs/2019c512_10_outgoingcorrespondence_20190806_111502906.pdf | ||||
| 20/03/2019 | Abstract Product Characteristics | Abstract of the characteristics of the product | 36 | /1/6/6/4/3/0721834661/docs/2019c512_11_abstractproductcharacteristics_20190321_082307554.pdf | |||
| 29/03/2019 | Publication | I1 | 1 | /1/6/6/4/3/0721834661/docs/2019c512_12_i1document_20190329_094942825.pdf | |||
| 09/09/2019 | General Document | Other | 2 | /1/6/6/4/3/0721834661/docs/2019c512_13_generaldocument_20190910_082305984.pdf | |||
| 21/03/2019 | Incoming Correspondence (Email) | Cover letter | 1 | /1/6/6/4/3/0721834661/docs/2019c512_14_incomingcorrespondenceelectronic_20190322_082414935.pdf | |||
| 21/09/2020 | Incoming Correspondence (Email) | Cover letter | 8 | /1/6/6/4/3/0721834661/docs/2019c512_15_incomingcorrespondenceelectronic_20200922_084828836.pdf | |||
| 29/03/2019 | Outgoing Correspondence | 2 | /1/6/6/4/3/0721834661/docs/2019c512_16_outgoingcorrespondence_20190401_114533798.pdf | ||||
| 20/03/2019 | Marketing Authorization | 1st Marketing Authorization (EU) | 3 | /1/6/6/4/3/0721834661/docs/2019c512_17_marketingauthorization_20190321_082328812.pdf | |||
| 21/03/2019 | General Document | Other | 1 | /1/6/6/4/3/0721834661/docs/2019c512_18_generaldocument_20190322_082418127.pdf | |||
| 20/03/2019 | MA Official Publication | Official Publication of 1st Marketing Authorization | 5 | /1/6/6/4/3/0721834661/docs/2019c512_19_maofficialpublication_20190321_082327634.pdf | |||
| 18/03/2020 | Incoming Correspondence (Email) | Cover letter | 5 | /1/6/6/4/3/0721834661/docs/2019c512_20_incomingcorrespondenceelectronic_20200319_082216950.pdf | |||
| 20/08/2020 | Outgoing Correspondence | 3 | /1/6/6/4/3/0721834661/docs/2019c512_21_outgoingcorrespondence_20200821_123839863.pdf | ||||
| 21/03/2019 | General Document | Other | 2 | /1/6/6/4/3/0721834661/docs/2019c512_22_generaldocument_20190322_082416908.pdf | |||
| 20/11/2019 | General Document | Other | 3 | /1/6/6/4/3/0721834661/docs/2019c512_23_generaldocument_20191120_105031844.pdf | |||
| 15/01/2020 | General Document | Other | 1 | /1/6/6/4/3/0721834661/docs/2019c512_24_generaldocument_20200115_034501169.pdf |